JOURNAL OF BUON, cilt.17, sa.1, ss.27-32, 2012 (SCI-Expanded)
Purpose: Although the use of regimens with adjuvant taxanes is a standard approach in node-positive breast cancer; the use of taxanes in node-negative breast cancer is still controversial. In this search, we aimed to evaluate the data about the use of taxanes in high-risk node-negative patients.